PACRG
Basic information
Region (hg38): 6:162727132-163315500
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (40 variants)
- not_provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PACRG gene is commonly pathogenic or not. These statistics are base on transcript: NM_001080379.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | |||||
| missense | 38 | 39 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 38 | 2 | 2 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PACRG | protein_coding | protein_coding | ENST00000337019 | 6 | 588361 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.43e-7 | 0.494 | 125698 | 0 | 50 | 125748 | 0.000199 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.884 | 130 | 162 | 0.804 | 0.00000881 | 1928 |
| Missense in Polyphen | 51 | 62.412 | 0.81715 | 702 | ||
| Synonymous | -0.482 | 70 | 65.0 | 1.08 | 0.00000404 | 573 |
| Loss of Function | 0.850 | 12 | 15.6 | 0.768 | 0.00000106 | 162 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000239 | 0.000239 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.000435 | 0.000435 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.000282 | 0.000281 |
| Middle Eastern | 0.000435 | 0.000435 |
| South Asian | 0.0000653 | 0.0000653 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Suppresses cell death induced by accumulation of unfolded Pael receptor (Pael-R, a substrate of Parkin). Facilitates the formation of inclusions consisting of Pael-R, molecular chaperones, protein degradation molecules and itself when proteasome is inhibited. May play an important role in the formation of Lewy bodies and protection of dopaminergic neurons against Parkinson disease. {ECO:0000269|PubMed:14532270}.;
Recessive Scores
- pRec
- 0.173
Intolerance Scores
- loftool
- 0.348
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.53
Haploinsufficiency Scores
- pHI
- 0.116
- hipred
- N
- hipred_score
- 0.187
- ghis
- 0.556
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.797
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pacrg
- Phenotype
Gene ontology
- Biological process
- spermatid development;cellular response to unfolded protein;negative regulation of cell death
- Cellular component
- nucleus;cytosol;vesicle;neuron projection;cell body;sperm midpiece
- Molecular function
- G protein-coupled receptor binding;actin binding;Hsp70 protein binding;heat shock protein binding;ubiquitin protein ligase binding;alpha-tubulin binding;beta-tubulin binding;chaperone binding;Hsp90 protein binding